SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
An open trial of fluoxetine in the treatment of panic attacks.
0 references·16 citing·52 second hop
An open trial of fluoxetine in the treatment of panic attacks. (1987)An open trial of fluoxetine in the treatm…Two-Week Treatment With the Selective Serotonin Reuptake Inhibitor Citalopram Reduces Contextual Anxiety but Not Cued Fear in Healthy Volunteers: A Fear-Potentiated Startle Study (2008)Two-Week Treatment With the S…Suicidality, violence and mania caused by selective serotonin reuptake inhibitors (SSRIs): A review and analysis (2004)Suicidality, violence and man…Generalized Anxiety Disorder in Patients With Major Depression: Is DSM-IV’s Hierarchy Correct? (2003)Generalized Anxiety Disorder …SSRIs vs. TCAs in the treatment of panic disorder: a meta‐analysis (2002)SSRIs vs. TCAs in the treatme…Mirtazapine versus fluoxetine in the treatment of panic disorder (2001)Mirtazapine versus fluoxetine…Sertraline in the Treatment of Panic Disorder: A Double-Blind Multicenter Trial (1998)Sertraline in the Treatment o…Outcome Assessment and Clinical Improvement in Panic Disorder: Evidence From a Randomized Controlled Trial of Fluoxetine and Placebo (1998)Outcome Assessment and Clinic…A Risk-Benefit Assessment of Buspirone in the Treatment of Anxiety Disorders (1997)A Risk-Benefit Assessment of …A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder (1997)A comparison of paroxetine, c…Fluoxetine for Childhood Anxiety Disorders (1994)Fluoxetine for Childhood Anxi…Effects of treatment with imipramine and clonazepam on an animal model of panic disorder (1994)Effects of treatment with imi…Antidepressant Drugs and the Emergence of Suicidal Tendencies (1993)Antidepressant Drugs and the …5-HT1A receptor-effector system responsivity in panic disorder (1992)5-HT1A receptor-effector syst…Emergence of Self-Destructive Phenomena in Children and Adolescents during Fluoxetine Treatment (1991)Emergence of Self-Destructive…Behavioral, neuroendocrine, and biochemical effects of 5-hydroxytryptophan administration in panic disorder (1990)Behavioral, neuroendocrine, a…Behavioral and Physiologic Effects of Short-term and Long-term Administration of Clonidine in Panic Disorder (1989)Behavioral and Physiologic Ef…Effect of a Serotonin and Noradrenaline Uptake Inhibitor in Panic Disorder; a Double-blind Comparative Study with Fluvoxamine and Maprotiline (1988)A Comparison of Cognitive Therapy, Applied Relaxation and Imipramine in the Treatment of Panic Disorder (1994)Comparison of Aerobic Exercise, Clomipramine, and Placebo in the Treatment of Panic Disorder (1998)Economic costs of full-blown and subthreshold panic disorder (2007)Empirically Supported Treatments for Panic Disorder (2009)Pharmacotherapy of anxiety disorders: a critical review (2011)A RATING SCALE FOR DEPRESSION (1960)The Anxiety Disease (1984)Multicenter Collaborative Panic Disorder Severity Scale (1997)Pindolol Augmentation in Patients With Treatment-Resistant Panic Disorder: A Double-Blind, Placebo-Controlled Trial (2000)A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder (2006)Psychopharmacology: The third generation of progress (1988)Psychopharmacology: The Third Generation of Progress. (1988)Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States (1994)Depression, Family Environment, and Adolescent Suicidal Behavior (1996)Treatment of School Refusal: One-Year Follow-up (2001)Update on and Advances in Assessment and Cognitive-Behavioral Treatment of Anxiety Disorders in Children and Adolescents. (2004)Delineation of two drug-responsive anxiety syndromes (1964)Treatment of Endogenous Anxiety With Phobic, Hysterical, and Hypochondriacal Symptoms (1980)Diagnostic and Statistical Manual of Mental Disorders (1988)Long‐term evaluation of paroxetine, clomipramine and placebo in panic disorder (1997)Escitalopram in the Treatment of Panic Disorder (2003)Anxiety disorders: a comprehensive review of pharmacotherapies (2008)Psychiatric disorders in America (1991)Overview of different pharmacotherapies for attaining remission in generalized anxiety disorder. (2001)Diagnostic and Statistical Manual of Mental Disorders (2013)Pharmacotherapy for social anxiety disorder (SAnD) (2017)Development of a Rating Scale for Primary Depressive Illness (1967)A Hundred Cases of Suicide: Clinical Aspects (1974)A New Depression Scale Designed to be Sensitive to Change (1979)Cost-effectiveness comparisons using “real world” randomized trials: The case of new antidepressant drugs (1995)Suicide Attempts Among Patients Starting Depression Treatment With Medications or Psychotherapy (2007)Antidepressant Utilization and Suicide in Europe: An Ecological Multi-National Study (2013)THE ASSESSMENT OF ANXIETY STATES BY RATING (1959)Normative and reliability data for the children's depression inventory (1986)Antidepressant Medications and the Relative Risk of Suicide Attempt and Suicide (1992)Reduction by Paroxetine of Suicidal Behavior in Patients With Repeated Suicide Attempts But Not Major Depression (1998)The Risk of Suicide With Selective Serotonin Reuptake Inhibitors in the Elderly (2006)A Rating Instrument For Anxiety Disorders (1971)SCL-90: an outpatient psychiatric rating scale--preliminary report. (1973)A Diagnostic Interview (1978)Adrenergic status in anxiety disorders: Platelet alpha2-adrenergic receptor binding, blood pressure, pulse, and plasma catecholamines in panic and generalized anxiety disorders patients and in normal subjects (1990)The prediction of nonresponse to pharmacotherapy in panic disorder: A review (2001)Australian and New Zealand Clinical Practice Guidelines for the Treatment of Panic Disorder and Agoraphobia (2003)The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. (1992)The MOS 36-ltem Short-Form Health Survey (SF-36) (1992)Is generalized anxiety disorder an anxiety or mood disorder? Considering multiple factors as we ponder the fate of GAD (2008)Suicidal ideation and anxiety disorders: Elevated risk or artifact of comorbid depression? (2008)Regulatory focus and anxiety: A self-regulatory model of GAD-depression comorbidity (2011)Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. (1993)Current treatments of the anxiety disorders in adults (1999)Quality of Life in the Anxiety Disorders (2000)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 1991Emergence of Self-Destructive Phenomena in Children and Adolescents during Fluoxetine Treatment191 cited
  • 2002SSRIs vs. TCAs in the treatment of panic disorder: a meta‐analysis186 cited
  • 1997A Risk-Benefit Assessment of Buspirone in the Treatment of Anxiety Disorders181 cited
  • 1993Antidepressant Drugs and the Emergence of Suicidal Tendencies168 cited
  • 1997A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder153 cited
  • 1994Fluoxetine for Childhood Anxiety Disorders147 cited
  • 1998Sertraline in the Treatment of Panic Disorder: A Double-Blind Multicenter Trial133 cited
  • 1998Outcome Assessment and Clinical Improvement in Panic Disorder: Evidence From a Randomized Controlled Trial of Fluoxetine and Placebo124 cited
  • 2003Generalized Anxiety Disorder in Patients With Major Depression: Is DSM-IV’s Hierarchy Correct?113 cited
  • 1989Behavioral and Physiologic Effects of Short-term and Long-term Administration of Clonidine in Panic Disorder107 cited
  • 19925-HT1A receptor-effector system responsivity in panic disorder104 cited
  • 1990Behavioral, neuroendocrine, and biochemical effects of 5-hydroxytryptophan administration in panic disorder96 cited
  • 1994Effects of treatment with imipramine and clonazepam on an animal model of panic disorder94 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2001Mirtazapine versus fluoxetine in the treatment of panic disorder93 cited
  • 2008Two-Week Treatment With the Selective Serotonin Reuptake Inhibitor Citalopram Reduces Contextual Anxiety but Not Cued Fear in Healthy Volunteers: A Fear-Potentiated Startle Study88 cited
  • 2004Suicidality, violence and mania caused by selective serotonin reuptake inhibitors (SSRIs): A review and analysis80 cited